$6.04
Today
as of Sep 4, 16:45 ET
Last 30 days
Recent Press Releases & News
Artelo Biosciences Announces Reverse Stock Split
Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
Overview
52-week range
$4.68
$179
1% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+2.1%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.89 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $4.00 | — | — | +655.6% | +1.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-3.97 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-5.61 | — | — | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.72 | — | — | — | +3.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.10 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-4.52 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.83 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-3M | — | $-3M | $-3M | $-2M | — | $-1M |
| Net income | $-2M | $-3M | — | $-3M | $-3M | $-2M | — | $-1M |
| EPS (diluted) | $-0.89 | $-4.00 | — | $-3.97 | $-16.86 | $-12.55 | — | $-2.10 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | $4M | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $4M | $10M | $695,000 | $2M | $2M | — | $3M | $5M |
| Total assets | $6M | $13M | $3M | $4M | $4M | — | $5M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1M | $6M | $4M | $5M | $6M | — | $2M | $775,000 |
| Total equity | $5M | $7M | $-1M | $-633,000 | $-1M | $652,000 | $3M | $6M |
Implied volatility — last 90 days
No IV snapshots yet for ARTL.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.